Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gontivimab (ALX-0171; VR-465), a potent anti-RSV prefusion F protein nanobody, exhibits antiviral activity by reducing the RSV load in the nose and lung, with a dissociation constant (K D) of 0.113 nM [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Gontivimab (ALX-0171; VR-465), a potent anti-RSV prefusion F protein nanobody, exhibits antiviral activity by reducing the RSV load in the nose and lung, with a dissociation constant (K D) of 0.113 nM [1]. |
Molecular Weight | N/A |
CAS No. | 1257358-38-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gontivimab 1257358-38-5 inhibitor inhibit